TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2025 Earnings Call Transcript August 4, 2025
TG Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.32.
Operator: Greetings. Welcome to TG Therapeutics’ Second Quarter Earnings Call and Webcast. [Operator Instructions] Please note, this conference is being recorded. At this time, I’ll turn the conference call over to Jenna Bosco, Chief Communications Officer. Jenna, you may now begin.
Jenna Bosco: Thank...
